LRRC75B/FAM211B anticorps (Cy7)
-
- Antigène Tous les produits LRRC75B/FAM211B (C22orf36)
- LRRC75B/FAM211B (C22orf36) (Chromosome 22 Open Reading Frame 36 (C22orf36))
- Reactivité
- Humain, Rat, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp LRRC75B/FAM211B est conjugé à/à la Cy7
-
Application
- Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Réactivité croisée
- Humain, Souris, Rat
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human C22orf36
- Isotype
- IgG
-
-
- Indications d'application
- IF(IHC-P) 1:50-200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- LRRC75B/FAM211B (C22orf36) (Chromosome 22 Open Reading Frame 36 (C22orf36))
- Autre désignation
- C22orf36 (C22orf36 Produits)
- Synonymes
- anticorps C22orf36, anticorps AI646023, anticorps leucine rich repeat containing 75B, anticorps LRRC75B, anticorps Lrrc75b
- Sujet
-
Synonyms: C22orf36, Leucine-rich repeat-containing protein C22orf36, chromosome 22 open reading frame 36, LRC6X_HUMAN.
Background: C22orf36 is a 315 amino acid protein that contains two LRR (leucine-rich) repeats and exists as two alternatively spliced isoforms. C22orf36 is encoded by a gene located on human chromosome 22, which contains over 500 genes and about 49 million bases. As the second smallest human chromosome, chomosome 22 contains a wide variety of genes with numerous functions. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia.
- ID gène
- 388886
-